DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Neuropsychopharmacology
Neuropsychopharmacology
The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus Lee A
M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Defic
Early-Life Experience, Epigenetics, and the Developing Brain
Mechanism of Action of Antidepressants and Mood Stabilizers
Neuropsychopharmacology (2015) 40, 2853–2855 © 2015 American College of Neuropsychopharmacology
Pharmacogenomics: the Promise of Personalized Medicine for CNS Disorders
Before They Called It Psychopharmacology* Heinz E
Neuropsychopharmacology - Mirjam A.F.M
Pharmacogenomic Testing for Selected Conditions Final Evidence Report
Neuropsychopharmacology of JNJ-55308942: Evaluation of a Clinical Candidate Targeting P2X7 Ion Channels in Animal Models of Neuroinflammation and Anhedonia
Effects of the Kappa-Opioid Receptor Agonist, U69593, on the Development of Sensitization and on the Maintenance of Cocaine Self
Thomas A. Ban Documenting the History of CINP
Partial Dopamine D2/Serotonin 5-HT1A Receptor Agonists As New Therapeutic Agents Adeline Etievant#, Cécile Bétry#, and Nasser Haddjeri*,1
Neuroscience-Based Nomenclature (Nbn) for Clinical Psychopharmacology and Neuroscience
Front Matter
Molecular and Cell Biological Approaches to Studying G-Protein–Coupled Receptors
Pharmacogenomics
Evaluation of Substituted N-Phenylpiperazine Analogs As D3 Vs
Top View
Genetic Contributions to Alcohol Use Disorder Treatment Outcomes: a Genome-Wide Pharmacogenomics Study ✉ Joanna M
Acute Toxic Effects of Club Drugs
Antidepressant Effect of Methanol Root Bark Extract of Acacia Seyal Del
ACNP Mission Statement
Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms
WHO Expert Committee on Drug Dependence Pre-Review ……………
Selective Kappa-Opioid Antagonism Ameliorates Anhedonic Behavior: Evidence from the Fast-Fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
Ligand Functional Selectivity Advances Our Understanding of Drug
The Selective Serotonin-2A Receptor Antagonist M100907 Reverses Behavioral Deficits in Dopamine Transporter Knockout Mice
Key Concepts in Psychopharmacology
[3H]PD 128907, a Putatively Selective Ligand for the D3 Dopamine Receptor, in Rat Brain: a Receptor Binding and Quantitative Autoradiographic Study Gregory N
(MDMA, “Ecstasy”) Investigator's Brochure
The Pharmacology of Psilocybin
Principles of Neuropsychopharmacology
Ethanol Potently and Competitively Inhibits Binding of the Alcohol Antagonist Ro15-4513 to ␣4/63␦ GABAA Receptors H
5-HT Receptors and the Development of New Antidepressants
Accepted Manuscript
Current Concepts and Treatments of Schizophrenia